The Co-Editors-in-Chief of Cardiovascular Innovations and Applications (CVIA), Jamie B. Conti, University of Florida, Gainesville, FL, USA, Jianzeng Dong, Beijing Anzhen Hospital, Capital Medical University, Beijing, China and Jun Pu, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, are pleased to announce that the 2024 Journal Impact Factor (JIF) for CVIA is 1.4.
Submissions to Cardiovascular Innovations and Applications (CVIA) can be made using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.
Articles of interest include:
Machine Learning Methods in Real-World Studies of Cardiovascular Disease
The Evolving Role of Transcatheter Tricuspid Valve Edge-to-Edge Repair in Tricuspid Regurgitation
Overview of Postural Orthostatic Tachycardia Syndrome (POTS) for General Cardiologists
Heart Failure Guideline Directed Medical Therapy: Which One and When?
Overview of Injectable Hydrogels for the Treatment of Myocardial Infarction
Surgical Treatment of Aortic Annulus Damaged by Infective Endocarditis: A Single-Center Experience
Cardiovascular Innovations and Applications is indexed in the SCOPUS, EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life, CNKI Scholar (Chinese National Knowledge Infrastructure) and Ulrich’s web Databases.
Comments (0)